Search Medical Condition
Please enter condition
Please choose location from dropdown

Fungal Infections Clinical Trials

A listing of Fungal Infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (21) clinical trials

Study to evaluate the safety and effectiveness of Naftin Cream 2% in pediatric subjects with Ringworm (Tinea Corporis).

Phase N/A

Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients

With compromised bone marrow function, patients with aplastic anemia (AA) and/and hypoplastic myelodysplastic syndrome (hMDS) are at an increased risk of invasive fungal infection. Moreover, the use of antithyocyte globulin (ATG), a part of standard first line treatment for AA/hMDS, increases the risk of fungal infection due to its antilymophocytic ...

Phase

Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)

The purpose of this study is to validate the diagnostic accuracy of a novel host-response based diagnostic tool for differentiating between bacterial and viral etiologies in adult patients aged 18 years and older with clinical suspicion of lower respiratory tract infections (LRTI)

Phase N/A

Studies of Disorders With Increased Susceptibility to Fungal Infections

This study is designed for the evaluation, diagnosis, and long-term follow up of selected patients with primary immune deficiencies and other conditions associated with fungal, and more specifically with Candida spp. infections. The primary immune deficiencies to be studied include, but are not limited to, autoimmune polyendocrinopathy candidiasis ectodermal dystrophy ...

Phase N/A

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

The aim of this study is to: Evaluate the clinical outcome of two different dosing regimen of IV colistin in the treatment of children with multidrug resistant gram-negative infections or sepsis. To estimate the frequency of colistin associated adverse effects. To correlate the serum colistin concentration and MIC to microbiological ...

Phase

Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology Management and Outcome

The prospective study will describe the epidemiology of IMIs in ICUs in India. The study will describe the incidence, risk factors, fungi causing IMIs and their susceptibility against antifungal agents, as well as the current strategies adopted by ICU physicians in the management of IMIs. It will also describe the ...

Phase N/A

Etiologies Investigations and Outcomes of Patients Presenting With Hemoptysis

RATIONALE Hemoptysis, mild or massive, is worrisome for both patients and physicians. The management is different depending on the causes, which are not well defined for the North American population. Despite the fact that this symptom is commonly reported in clinic, there are only a few studies published on this ...

Phase N/A

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Non-myeloablative approach for allogeneic transplant is a reasonable option, especially given that the median age at diagnosis is 55-60 years and frequently present compromised skin in these patients, which increases the risk of infection. Therefore, we propose a clinical study with allogeneic HSCT using a unique non-myeloablative preparative regimen, TLI/ATG, ...

Phase

Pharmacokinetics of Posaconazole (Noxafil ) as Prophylaxis for Invasive Fungal Infections

In 2014, the new intravenous and solid oral formulation of posaconazole were marketed. This offers new treatment possibilities, specifically in patients previously unable to attain adequate exposure to posaconazole solution. To the opinion of the researchers, only limited data are available on the pharmacokinetics (PK) of the new formulations of ...

Phase

Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections

Samples from immunosuppressed patients with febrile neutropenia will be taken: at the start of neutropenic fever after 24 hours after 48 hours before the start of antimycotic therapy, if pertinent at the end of antimycotic therapy, if pertinent The results ot analyses by a panfungal PCR screening assay developed at ...

Phase N/A